What is the Role of Urine Drug Testing (UDT) in the management of chronic non-cancer pain with opioids?

Pain Medicine (United States)

Volumn 13, Issue 7, 2012, Pages 853-856

  Schonwald, Gabriel ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE;

CHRONIC PAIN; CLINICAL ASSESSMENT TOOL; DRUG MONITORING; DRUG TOLERANCE; EDITORIAL; FORENSIC IDENTIFICATION; HUMAN; IMMUNOASSAY; POINT OF CARE TESTING; TREATMENT OUTCOME; URINALYSIS; URINE DRUG TESTING;

EID: 84863876641     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2012.01440.x     Document Type: Editorial

References (17)

1. CDC Grand Rounds: Prescription Drug Overdoses-a U.S. Epidemic Leonard Paulozzi, MD, Grant Baldwin, PhD, Div of Unintentional Injury Prevention, National Center for Injury Prevention and Control, CDC. Gary Franklin, MD, Washington State Agency Medical Directors' Group, Olympia, Washington. R. Gil Kerlikowske, MA, Christopher M. Jones, Pharm D, Office of National Drug Control Policy, Washington, DC. Neelam Ghiya, MPH, Tanja Popovic, MD, PhD, Office of the Director, CDC. January 13, 2012/61(01):10-3. Available at: (accessed June 25, 2012).
2. Ballantyne JC. Problems with chronic opioid therapy and the need for a multidisciplinary approach. In: Schatman ME, Campbell A, eds. Chronic Pain Management: Guidelines for Multidisciplinary Program Development. New York: Informa Healthcare; 2007:49-64.
3. AAPM. Safe Opioid Prescribing Course. 2012. Available at: (accessed June 25, 2012).
4. Peppin JF, etal. Recommendations for urine drug monitoring as a component of opioid therapy in the treatment of chronic pain. Pain Med 2012;13:886-96.
5. Pesce A, etal. Millennium Research Institute, Interpretation of urine drug testing in pain patients. Pain Med 2012;13:868-85.
6. Starrels JL, Becker WC, Alford DP, etal. Systematic review: Treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Ann Intern Med 2010;152(11):712-20.
7. Reisfield GM, Webb FJ, Bertholf RL, Sloan PA, Wilson GR. Family physicians' proficiency in urine drug test interpretation. J Opioid Manag 2007;3(6):333-7.
8. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Available at: (accessed June 25, 2012).
9. Laffer A, Murphy R, Wingarden W, etal. An economic analysis of the costs and benefits associated with regular urine drug testing for chronic pain patients in the United States. Laffer Associates and Millennium Research Institute: Washington DC, October 2011.
10. Singh N, Squier C, Sivek C, etal. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance. AIDS Care 1996;8(3):261-9.
11. Choudhry NK, Avorn J, Glynn RJ, etal. Post-myocardial infarction free Rx event and economic evaluation (MI FREEE) trial full coverage for preventive medications after myocardial infarction. N Engl J Med 2011;365:2088-97.
12. Broekmans S, Dobbels F, Milisen K, Morlion B, Vanderschueren S. Medication adherence in patients with chronic non-malignant pain: Is there a problem? Eur J Pain 2009;13:115-23. doi: 10.1016/j. ejpain. 2008.02. 010.
13. Drug screening: The next cash cow? Workers Comp Exec 2012;22(3):1.
14. Nafziger AN, Bertino JS Jr. Utility and application of urine drug testing in chronic pain management with opioids. Clin J Pain 2009;25:73-9.
15. Heit HA, Gourlay DL. Urine drug testing in pain medicine. J Pain Symptom Manage 2004;27(3):260-7.
16. Reisfield GM, Goldberger BA, Bertholf RL. "False-positive" and "false-negative" test results in clinical urine drug testing. Bioanalysis 2009;1(5):937-52.
17. Gourlay DL, Heit H. Universal precautions in pain medicine: A rational approach to the treatment of chronic pain. Pain Med 2005;6(2):107-12.